1-7 of 7 results for subject:Pfizer
Librarians' tools
- Search time
- 0.233 seconds
- Solr query time
- 0.001 seconds
- Search query
- subject:Pfizer
- We searched for
- subject_t:Pfizer OR subject_ses:61578
Type
House
Session
Year
Department
Member
More
Primary member
Answering member
Legislative stage
Legislation
Subject
More
Publisher
To ask the Secretary of State for Health what assessment he has made of the impact of the changes in distribution of Pfizer medicines on NHS patients.
To ask the Secretary of State for Health what assessment he has made of the impact of the changes in distribution of Pfizer medicines on NHS patients.
To ask the Secretary of State for Health if she will list the occasions on which she has met representatives of (a) Pfizer and (b) Alliance Unichem in the last six months.
To ask the Secretary of State for Health if she will list the occasions on which she has met representatives of (a) Pfizer and (b) Alliance Unichem in the last six months.
That this House shares the concerns expressed by pharmacists and dispensing clinicians about the potential impact on patient access to essential medicines of Pfizer's proposals for distributing its pharmaceutical products in the United Kingdom; believes that the new distribution arrangements represent an unacceptable risk by placing responsibility for distributing Pfizer's essential medicines to every pharmacy throughout the United Kingdom with just one company; notes that earlier this year Pfizer ran out of their own treatment for high blood pressure and the supply chain was only restored by access to stocks of the drug held within the existing network of distributors; recognises the bureaucratic burden these proposals would place on pharmacists at the expense of patient contact time; is concerned that the proposed arrangements might undermine NHS budgets and eradicate the choice and competition required to keep drug costs down and quality of service up within the NHS; and therefore calls upon the Government to ensure that Pfizer's anti-competitive, anti-community pharmacy, anti-patient and anti-NHS proposals are investigated by the appropriate agencies as a matter of urgency.
That this House shares the concerns expressed by pharmacists and dispensing clinicians about the potential impact on patient access to essential medicines of Pfizer's proposals for distributing its pharmaceutical products in the United Kingdom; believes that the new distribution arrangements represent an unacceptable risk by placing responsibility for distributing Pfizer's...
asked Her Majesty's Government:What representations they have received on the consequences for patients of Pfizer's decision, as the major supplier of medicines to the National Health Service, that from 5 March 2007 all its products will be distributed into the United Kingdom medical supply chain by one logistics service provider;...
asked Her Majesty's Government:What representations they have received on the consequences for patients of Pfizer's decision, as the major supplier of medicines to the National Health Service, that from 5 March 2007 all its products will be distributed into the United Kingdom medical supply chain by one logistics service provider;...
(2) if he will refer the proposal by Pfizer to sell its products through a single distribution channel from early 2007 to the Office of Fair Trading for review; and if he will make a statement.
(2) if he will refer the proposal by Pfizer to sell its products through a single distribution channel from early 2007 to the Office of Fair Trading for review; and if he will make a statement.
To ask the Secretary of State for Trade and Industry (1) what assessment his Department has made of the potential impact on (a) concurrent choice and (b) competition of the decision by Pfizer to sell its products through a single distribution channel;
To ask the Secretary of State for Trade and Industry (1) what assessment his Department has made of the potential impact on (a) concurrent choice and (b) competition of the decision by Pfizer to sell its products through a single distribution channel;